Home›Companies›Biotech & Pharma›LyGenesis

LyGenesis Inc.

Updated Oct 27, 2026·Latest SEC filing Oct 11, 2024·Suggest an edit

About LyGenesis

LyGenesis is a private company based in Pittsburgh, Pennsylvania. It has reported $25,825,226 raised in four offerings on Form D since May 2018. Its chief executive is Michael Hufford.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Oct 5, 2023Oct 12, 2023amended Oct 11, 2024$17,764,699of $20.0M target17$1.0MEquityRule 506(b)Form D/A ↗1 earlier filing
Dec 14, 2020Dec 23, 2020$1,850,000of $20.5M target7$264KEquity, Debt, Options, Securities on exerciseRule 506(b)Form D ↗
Oct 18, 2019Oct 22, 2019$4,000,000fully sold2$2.0MEquity, Debt, OptionsRule 506(b)Form D ↗
May 9, 2018May 18, 2018$2,210,527of $3.2M target2$1.1MEquityRule 506(b)Form D ↗
Total, four offerings$25,825,226

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on LyGenesis's Form D filed Oct 11, 2024.

JM
James Mellon
Director
SF
EL
Eric Lagasse
Executive officer and director
JB
MH
Michael Hufford
Chief Executive Officer and director

Earlier filings also listed Paulo Fontes (executive officer, last listed Dec 2020), Gregory Bailey (director, last listed Oct 2019) and Eric Legasse (executive officer and promoter, last listed Oct 2019).

Sources

  1. SECLyGenesis Inc. Form D, filed Oct 12, 2023
  2. SECLyGenesis Inc. filing history